What does CUSIP 52490G102 represent in this 13F holders report?

CUSIP 52490G102 is the security identifier for LEGN - Legend Biotech Corp - Ordinary Shares used to aggregate holder disclosures.

How many institutions held LEGN - Legend Biotech Corp - Ordinary Shares in Q2 2022?

147 institutional investors reported LEGN - Legend Biotech Corp - Ordinary Shares for Q2 2022. Use the holders table for investor-level position and value details.

Legend Biotech Corp - Ordinary Shares (LEGN)

CUSIP: 52490G102

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Ordinary Shares
Shares outstanding: 368,659,889
Total 13F shares: 52,707,652
Share change: +1,652,779
Total reported value: $2,898,825,468
Put/Call ratio: 43%
Price per share: $55.00
Number of holders: 147
Value change: +$118,361,366
Number of buys: 81
Number of sells: 70

Quarterly Holders Quick Answers

What is CUSIP 52490G102?
CUSIP 52490G102 identifies LEGN - Legend Biotech Corp - Ordinary Shares in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 52490G102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of LEGN - Legend Biotech Corp - Ordinary Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
HHLR ADVISORS, LTD.	13F	Company	1.9%	6,936,617	$252,077,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	0.83%	3,046,229	$110,701,000	—	31 Mar 2022	13F
Capital International Investors	13F	Company	0.76%	2,810,737	$102,142,000	—	31 Mar 2022	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.71%	2,609,818	$94,841,000	—	31 Mar 2022	13F
FMR LLC	13F	Company	0.66%	2,424,663	$88,113,000	—	31 Mar 2022	13F
Capital World Investors	13F	Company	0.6%	2,214,024	$80,458,000	—	31 Mar 2022	13F
FEDERATED HERMES, INC.	13F	Company	0.57%	2,112,895	$76,783,000	—	31 Mar 2022	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.56%	2,078,775	$75,543,000	—	31 Mar 2022	13F
BAKER BROS. ADVISORS LP	13F	Company	0.54%	2,008,999	$73,007,000	—	31 Mar 2022	13F
Artisan Partners Limited Partnership	13F	Company	0.48%	1,782,085	$64,761,000	—	31 Mar 2022	13F
Capital International, Inc./CA/	13F	Company	0.48%	1,763,090	$64,071,000	—	31 Mar 2022	13F
JOHNSON & JOHNSON	13F	Company	0.44%	1,629,173	$59,204,000	—	31 Mar 2022	13F
Hudson Bay Capital Management LP	13F	Company	0.35%	1,281,350	$46,564,000	—	31 Mar 2022	13F
Woodline Partners LP	13F	Company	0.32%	1,171,051	$42,556,000	—	31 Mar 2022	13F
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC	13F	Company	0.3%	1,100,542	$39,994,000	—	31 Mar 2022	13F
Avidity Partners Management LP	13F	Company	0.3%	1,095,000	$39,792,000	—	31 Mar 2022	13F
FengHe Fund Management Pte. Ltd.	13F	Company	0.27%	997,714	$36,257,000	—	31 Mar 2022	13F
Paradigm Biocapital Advisors LP	13F	Company	0.23%	831,728	$30,225,000	—	31 Mar 2022	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.22%	810,000	$29,435,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	0.19%	682,346	$24,796,000	—	31 Mar 2022	13F
Bellevue Group AG	13F	Company	0.18%	660,069	$23,987,000	—	31 Mar 2022	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.17%	616,141	$22,391,000	—	31 Mar 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.15%	565,924	$20,566,000	—	31 Mar 2022	13F
Bridgewater Associates, LP	13F	Company	0.15%	543,206	$19,740,000	—	31 Mar 2022	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.13%	471,002	$17,116,213	—	31 Mar 2022	13F
FRANKLIN RESOURCES INC	13F	Company	0.12%	448,216	$16,288,000	—	31 Mar 2022	13F
Rock Springs Capital Management LP	13F	Company	0.11%	411,184	$14,942,000	—	31 Mar 2022	13F
JPMORGAN CHASE & CO	13F	Company	0.11%	405,401	$14,733,000	—	31 Mar 2022	13F
Polar Capital Holdings Plc	13F	Company	0.1%	374,870	$13,623,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.1%	366,864	$13,332,000	—	31 Mar 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	0.1%	364,922	$13,261,000	—	31 Mar 2022	13F
Allianz Asset Management GmbH	13F	Company	0.08%	313,016	$11,375,000	—	31 Mar 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.07%	259,995	$9,449,000	—	31 Mar 2022	13F
CANADA PENSION PLAN INVESTMENT BOARD	13F	Company	0.07%	257,300	$9,351,000	—	31 Mar 2022	13F
BARCLAYS PLC	13F	Company	0.07%	245,326	$8,915,000	—	31 Mar 2022	13F
Vivo Capital, LLC	13F	Company	0.07%	244,375	$8,881,000	—	31 Mar 2022	13F
DEUTSCHE BANK AG\	13F	Company	0.07%	244,085	$8,870,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.06%	229,541	$8,292,000	—	31 Mar 2022	13F
Capital International Sarl	13F	Company	0.06%	225,880	$8,208,000	—	31 Mar 2022	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.06%	218,015	$7,923,000	—	31 Mar 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.05%	183,862	$6,682,000	—	31 Mar 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.05%	181,100	$6,581,000	—	31 Mar 2022	13F
Legal & General Group Plc	13F	Company	0.05%	180,583	$6,562,000	—	31 Mar 2022	13F
ArrowMark Colorado Holdings LLC	13F	Company	0.05%	165,981	$6,032,000	—	31 Mar 2022	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.04%	165,132	$6,000,897	—	31 Mar 2022	13F
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F	Company	0%	4,500	$5,632,000	—	31 Mar 2022	13F
SG Americas Securities, LLC	13F	Company	0.04%	154,215	$5,604,000	—	31 Mar 2022	13F
CREDIT SUISSE AG/	13F	Company	0.04%	135,978	$4,941,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0.04%	135,538	$4,926,000	—	31 Mar 2022	13F
CLOUGH CAPITAL PARTNERS L P	13F	Company	0.04%	129,691	$4,713,000	—	31 Mar 2022	13F

Institutional Holders of Legend Biotech Corp - Ordinary Shares (LEGN) as of Q2 2022

As of 30 Jun 2022, Legend Biotech Corp - Ordinary Shares (LEGN) was held by 147 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 52,707,652 shares. The largest 10 holders included FMR LLC, HHLR ADVISORS, LTD., BlackRock Inc., Capital International Investors, WELLINGTON MANAGEMENT GROUP LLP, Capital World Investors, FEDERATED HERMES, INC., Artisan Partners Limited Partnership, JOHNSON & JOHNSON, and ALLIANCEBERNSTEIN L.P.. This page lists 148 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

137

Q2 2022 holders

147

Holder diff

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.